Targeting A Key Actor In The Spread Of Triple Negative Breast Cancer
This article was originally published in Start Up
Executive Summary
Researchers have identified a molecule found in primary tumors whose suppression leads to metastasis of cancer cells to the lung and lymph nodes. Their findings, which dovetail nicely with clinical research efforts at several companies, could quickly lead to testing of drugs to treat triple negative breast cancer, which has the worst outcome among breast cancer patients due to the high incidence of recurrence and metastatic spread.